{"id":"https://openalex.org/W4386024239","doi":"https://doi.org/10.1097/01.hs9.0000969544.86164.65","title":"P660: NEXT-GENERATION SEQUENCING (NGS) FOR DETECTING BCR::ABL-INDEPENDENT MUTATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WITH RESISTANCE TO TYROSINE KINASE INHIBITOR TREATMENT","display_name":"P660: NEXT-GENERATION SEQUENCING (NGS) FOR DETECTING BCR::ABL-INDEPENDENT MUTATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WITH RESISTANCE TO TYROSINE KINASE INHIBITOR TREATMENT","publication_year":2023,"publication_date":"2023-08-01","ids":{"openalex":"https://openalex.org/W4386024239","doi":"https://doi.org/10.1097/01.hs9.0000969544.86164.65","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10428805"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000969544.86164.65","doi":"https://doi.org/10.1097/01.hs9.0000969544.86164.65","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000969544.86164.65","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000969544.86164.65","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054934805","display_name":"Daria V. Kustova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132518","display_name":"Russian Research Institute of Hematology and Transfusiology","ror":"https://ror.org/02z8dkq59","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210132518"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Daria Kustova","raw_affiliation_strings":["Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia","institution_ids":["https://openalex.org/I4210132518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030357451","display_name":"Anna Kirienko","orcid":"https://orcid.org/0000-0002-2519-306X","observed_orcids":["https://orcid.org/0000-0002-2519-306X"]},"institutions":[{"id":"https://openalex.org/I4210132518","display_name":"Russian Research Institute of Hematology and Transfusiology","ror":"https://ror.org/02z8dkq59","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210132518"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Anna Kirienko","raw_affiliation_strings":["Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia","institution_ids":["https://openalex.org/I4210132518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113348723","display_name":"Ekaterina Motyko","orcid":"https://orcid.org/0000-0002-6052-6472","observed_orcids":["https://orcid.org/0000-0002-6052-6472"]},"institutions":[{"id":"https://openalex.org/I4210132518","display_name":"Russian Research Institute of Hematology and Transfusiology","ror":"https://ror.org/02z8dkq59","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210132518"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Ekaterina Motyko","raw_affiliation_strings":["Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia","institution_ids":["https://openalex.org/I4210132518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077933082","display_name":"Vasily A. Shuvaev","orcid":"https://orcid.org/0000-0003-3536-0770","observed_orcids":["https://orcid.org/0000-0003-3536-0770"]},"institutions":[{"id":"https://openalex.org/I4210132518","display_name":"Russian Research Institute of Hematology and Transfusiology","ror":"https://ror.org/02z8dkq59","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210132518"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Vasily Shuvaev","raw_affiliation_strings":["Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia","institution_ids":["https://openalex.org/I4210132518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103211282","display_name":"Elizaveta Efremova","orcid":"https://orcid.org/0000-0002-8695-2816","observed_orcids":["https://orcid.org/0000-0002-8695-2816"]},"institutions":[{"id":"https://openalex.org/I4210132518","display_name":"Russian Research Institute of Hematology and Transfusiology","ror":"https://ror.org/02z8dkq59","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210132518"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Elizaveta Efremova","raw_affiliation_strings":["Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia","institution_ids":["https://openalex.org/I4210132518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002853101","display_name":"Elena Vladislavovna Morozova","orcid":"https://orcid.org/0000-0002-0125-864X","observed_orcids":["https://orcid.org/0000-0002-0125-864X"]},"institutions":[{"id":"https://openalex.org/I2799540354","display_name":"First Pavlov State Medical University of St. Petersburg","ror":"https://ror.org/04g525b43","country_code":"RU","type":"education","lineage":["https://openalex.org/I2799540354"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Elena Morozova","raw_affiliation_strings":["Pavlov First State Medical University, Saint Petersburg, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pavlov First State Medical University, Saint Petersburg, Russia","institution_ids":["https://openalex.org/I2799540354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005117727","display_name":"Sergey V. Sidorkevich","orcid":"https://orcid.org/0000-0001-9931-9406","observed_orcids":["https://orcid.org/0000-0001-9931-9406"]},"institutions":[{"id":"https://openalex.org/I4210132518","display_name":"Russian Research Institute of Hematology and Transfusiology","ror":"https://ror.org/02z8dkq59","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210132518"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Sergey Sidorkevich","raw_affiliation_strings":["Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia","institution_ids":["https://openalex.org/I4210132518"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026965940","display_name":"\u041c\u0430\u0440\u0442\u044b\u043d\u043a\u0435\u0432\u0438\u0447 \u0418\u0440\u0438\u043d\u0430 \u0421\u0442\u0435\u043f\u0430\u043d\u043e\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0001-5958-0490","observed_orcids":["https://orcid.org/0000-0001-5958-0490"]},"institutions":[{"id":"https://openalex.org/I4210132518","display_name":"Russian Research Institute of Hematology and Transfusiology","ror":"https://ror.org/02z8dkq59","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210132518"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Irina Martynkevich","raw_affiliation_strings":["Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia","institution_ids":["https://openalex.org/I4210132518"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"S3","first_page":"e8616465","last_page":"e8616465"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitor-resistance","display_name":"tyrosine kinase inhibitor resistance","score":0.8830000162124634},{"id":"https://openalex.org/keywords/next-generation-sequencing","display_name":"next-generation sequencing","score":0.6759999990463257},{"id":"https://openalex.org/keywords/nf1-mutation","display_name":"NF1 mutation","score":0.7210000157356262},{"id":"https://openalex.org/keywords/tet2-mutation","display_name":"TET2 mutation","score":0.9290000200271606},{"id":"https://openalex.org/keywords/atrx-mutation","display_name":"ATRX mutation","score":0.9779999852180481},{"id":"https://openalex.org/keywords/stag2-mutation","display_name":"STAG2 mutation","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.5180000066757202},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.4490000009536743},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.4230000078678131},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.3100000023841858},{"id":"https://openalex.org/keywords/targeted-therapy-selection","display_name":"targeted therapy selection","score":0.5320000052452087}],"concepts":[{"id":"https://openalex.org/C76818968","wikidata":"https://www.wikidata.org/wiki/Q181940","display_name":"Sanger sequencing","level":4,"score":0.7108216285705566},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.701723039150238},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6971867084503174},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5970720052719116},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5559294819831848},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.534964382648468},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48577478528022766},{"id":"https://openalex.org/C2781107747","wikidata":"https://www.wikidata.org/wiki/Q1898104","display_name":"Myeloproliferative neoplasm","level":4,"score":0.46771305799484253},{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.46342766284942627},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.43053358793258667},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.42837071418762207},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.399325430393219},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.345228374004364},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2283412516117096},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.18994495272636414},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16886255145072937},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.16749495267868042},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.10787409543991089},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.07549497485160828},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000969544.86164.65","doi":"https://doi.org/10.1097/01.hs9.0000969544.86164.65","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000969544.86164.65","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10428805","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10428805","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10428805/pdf/hs9-7-e8616465.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:f9bafdc085eb493995f8eb513ea6d088","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f9bafdc085eb493995f8eb513ea6d088","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 7, p e8616465 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000969544.86164.65","doi":"https://doi.org/10.1097/01.hs9.0000969544.86164.65","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000969544.86164.65","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386024239.pdf","grobid_xml":"https://content.openalex.org/works/W4386024239.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4296965576","https://openalex.org/W3096932708","https://openalex.org/W2301146803","https://openalex.org/W4394975735","https://openalex.org/W4296468304","https://openalex.org/W7204709858","https://openalex.org/W4389229631","https://openalex.org/W4310119546","https://openalex.org/W2810894541","https://openalex.org/W2980302308"],"abstract_inverted_index":{"Background:":[0],"Chronic":[1,545],"myeloid":[2,209,546],"leukemia":[3],"(CML)":[4],"is":[5,19],"a":[6,78,133,158,208,224,356,475],"myeloproliferative":[7],"neoplasm":[8],"associated":[9,422],"with":[10,21,124,132,157,216,251,267,417,423,442,449,464,520],"the":[11,14,31,35,38,54,58,93,171,175,200,205,232,238,248,256,261,265,302,326,330,333,365,391,398,428,436,456,483,490,493,510,539,542],"presence":[12,27,190,431,457],"of":[13,28,34,40,51,60,81,104,120,136,161,168,174,180,191,211,221,231,281,332,375,379,427,432,439,447,458,473,489,528,541],"chimeric":[15],"BCR::ABL":[16,36,176],"gene,":[17,469],"which":[18,523],"treated":[20],"tyrosine":[22],"kinase":[23,32,172],"inhibitors":[24],"(TKIs).":[25],"The":[26,115,141,166,189,228,430,497],"mutations":[29,45,76,169,233,283,291,299,322,381,394,406,434,460,466,508],"in":[30,49,64,77,170,178,264,276,301,325,329,359,372,397,407,467,509,518],"domain":[33,173],"causes":[37,59],"development":[39],"resistance":[41,61,87,105,192,268,450,535],"to":[42,62,74,88,106,149,193,199,269,285,383,415,451,492,505],"TKIs.":[43],"As":[44],"are":[46,389,421],"not":[47,480],"detected":[48,371],"100%":[50],"resistant":[52,125,418,521],"patients,":[53],"question":[55],"arises":[56],"about":[57],"therapy":[63,95,108,151,195,453],"these":[65,485],"patients.":[66,121],"Next":[67],"generation":[68,499],"sequencing":[69,500],"(NGS)":[70],"makes":[71,502],"it":[72,503],"possible":[73,504],"analyze":[75],"wide":[79],"range":[80],"genes,":[82],"evaluate":[83,538],"their":[84],"impact":[85],"on":[86,223,455],"TKI":[89,107,150,194,270,452],"therapy,":[90,271,474],"and":[91,129,154,241,312,315,345,355,401,409,420,537],"select":[92],"appropriate":[94],"for":[96],"each":[97],"patient.":[98],"Aims:":[99],"To":[100],"study":[101,116,263],"BCR::ABL-independent":[102,534],"pathways":[103,536],"using":[109,237,247,255],"modern":[110],"molecular":[111,477],"genetic":[112,272,368],"technologies.":[113],"Methods:":[114],"included":[117],"two":[118,462],"groups":[119,182],"32":[122],"patients":[123,146,179,441,448,463,486,519],"CML":[126,419,443],"(18":[127],"men":[128,153],"14":[130],"women)":[131,156],"median":[134,159],"age":[135,160],"44":[137],"(IQR":[138,163],"14-74":[139],"years).":[140,165],"control":[142,366],"group":[143,266],"was":[144,183,196,214,235,245,479],"11":[145],"who":[147],"responded":[148],"(5":[152],"6":[155],"58":[162],"33-75":[164],"absence":[167],"gene":[177,318,327,357],"both":[181],"confirmed":[184],"by":[185],"direct":[186],"Sanger":[187],"sequencing.":[188],"assessed":[197,236,254],"according":[198],"ELN":[201],"2021":[202],"criteria.":[203],"For":[204],"NGS":[206,262],"study,":[207],"panel":[210],"118":[212],"genes":[213,309,342,411,517],"used":[215],"an":[217,279,377,424],"average":[218,280,378],"reading":[219],"depth":[220],"1000x":[222],"MiSeq":[225],"instrument":[226],"(Illumina).":[227],"clinical":[229,294],"significance":[230,253],"found":[234,275,324,396],"COSMIC,":[239],"ClinVar,":[240],"VarSome":[242],"databases.":[243],"Survival":[244,446],"analyzed":[246],"Kaplan-Meier":[249],"method":[250,501,530],"statistical":[252],"Mantel-Cox":[257],"test.":[258],"Results:":[259],"During":[260],"abnormalities":[273,369],"were":[274,323,370,395],"all":[277],"patients:":[278,376],"5":[282],"(1":[284],"10":[286],"per":[287,385],"patient).":[288,386],"95%":[289],"(144/152)":[290],"had":[292],"unclear":[293],"significance:":[295],"most":[296,392],"often":[297],"such":[298],"occur":[300,416],"tumor":[303],"suppressor":[304],"NF1":[305,399],"(14),":[306],"transcription":[307,351],"regulator":[308],"TET2":[310,402],"(14)":[311],"ATRX":[313],"(11),":[314],"cohesin":[316],"complex":[317],"STAG2":[319],"(8).":[320],"Pathogenic":[321,405],"involved":[328,358],"activation":[331],"Ras/MAPK":[334],"cell":[335],"signaling":[336],"pathway":[337],"PTPN11":[338],"(1),":[339,350,354],"epigenetic":[340],"regulation":[341],"EZH2":[343],"(1)":[344],"ASXL1":[346,410,468],"(4),":[347],"proto-oncogene":[348],"RHOA":[349],"factor":[352],"RUNX1":[353,408,516],"DNA":[360],"methylation":[361],"DNMT3A":[362],"(1).":[363],"In":[364,461,482],"group,":[367],"81%":[373],"(9/11)":[374],"3":[380],"(0":[382],"4":[384],"All":[387],"variants":[388],"nonpathogenic:":[390],"frequent":[393],"(4)":[400],"(3)":[403],"genes.":[404],"have":[412],"been":[413],"noted":[414],"unfavorable":[425],"course":[426,540],"disease.":[429,543],"pathogenic":[433,459,465,507],"reduces":[435],"overall":[437],"survival":[438],"therapy-resistant":[440],"(Fig.":[444],"1).Fig.1.":[445],"depending":[454],"despite":[470],"several":[471],"lines":[472],"large":[476],"response":[478],"achieved.":[481],"future,":[484],"showed":[487],"progression":[488],"disease":[491],"blast":[494],"phase.":[495],"Summary/Conclusion:":[496],"latest":[498],"detect":[506],"PTPN11,":[511],"EZH2,":[512],"ASXL1,":[513],"RHOA,":[514],"DNMT3A,":[515],"CML,":[522],"significantly":[524],"worsen":[525],"survival.":[526],"Application":[527],"this":[529],"can":[531],"reveal":[532],"additional":[533],"Keywords:":[544],"leukemia,":[547],"Resistance":[548]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2023-08-22T00:00:00"}